Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAURITE 1: IPN10200 in Moderate to Severe Glabellar Lines
NCT07427797Phase 3Active, not recruiting
- Sponsor
- Ipsen
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Therapeutic Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of corabotase in glabellar lines, sponsored by Ipsen. Started Feb 2026; status: active, not recruiting.
02
Drugs
corabotase
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT07427797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07427797.